[1]
de Bruin-Weller, M., Thaci, D., Smith, C., Radin, A., Zhang, R., Akinlade, B., Gadkari, A., Eckert, L., Hultsch, T., Pirozzi, G., Graham, N.M. and Shumel, B. 2017. Dupilumab with Concomitant Topical Corticosteroids in Atopic Dermatitis Patients who are Inadequately Controlled with or Medically Inadvisable for Cyclosporine A: a Phase 3 Clinical Trial (LIBERTY AD CAFE). SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s37. DOI:https://doi.org/10.25251/skin.1.supp.36.